However, seeking professional supervision before increasing the dose is important as it may lead to increased side effects
da Silva HA, Sitta A, Barschak AG, Deon M, Barden AT, Schmitt GO, et al
Discontinue SAXENDA in patients who experience a sustained increase in resting heart rate [see Warnings and Precautions (5.5)]
Food and Drug Administration to continuously monitor the safety provide of our medicines and that patient safety is a top priority. Novo Nordisk stands behind the safety and efficacy of Ozempic and all of our medicines when used consistent with the product labeling and the approved indications said the statement
This is thought to affect angiogenic activity, fibroblast behavior, and collagen organization in tissue repair models